首页> 外文期刊>Journal of Cancer Research and Therapeutics >The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma
【24h】

The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma

机译:肝素酶mRNA在肝细胞癌中的表达及其临床意义。

获取原文
           

摘要

Objective: To investigate the clinico-pathologic importance of Heparanase mRNA expression in hepatocellular carcinoma and its relationship with prognosis. Materials and Methods: Fresh tumors and noncancerous liver tissues were obtained from 30 hepatocellular carcinoma patients after hepatectomy. Expression levels of Heparanase and glyceraldehyde-3-phosphate dehydrogenase mRNA were quantitatively analyzed by real-time reverse transcriptase-polymerase chain reaction. Results: The relative Heparanase mRNA expression level (Heparanase: glyceraldehyde-3-phosphate dehydrogenase ratio) in hepatocellular carcinoma was lower than that in noncancerous tissue (P 0.05). Conclusion: Reduced Heparanase mRNA expression might result in abnormal cell growth and correlate with hepatocellular carcinoma progression.
机译:目的:探讨肝素酶mRNA表达在肝细胞癌中的临床病理意义及其与预后的关系。材料与方法:从30例肝细胞癌肝切除患者中获得新鲜肿瘤和非癌性肝组织。通过实时逆转录酶-聚合酶链反应定量分析了乙酰肝素酶和3-磷酸甘油醛脱氢酶mRNA的表达水平。结果:肝细胞癌中相对肝素酶mRNA表达水平(肝素酶:甘油醛-3-磷酸脱氢酶比)低于非癌组织(P <0.05)。结论:降低的肝素酶mRNA表达可能导致异常细胞生长,并与肝细胞癌的进展相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号